Hepatocyte Nuclear Factor 4α is a Critical Factor for the Production of Complement Components in the Liver

Overview

Journal In Vitro Cell Dev Biol Anim

Publisher Springer

Specialties Biology
Cell Biology

Date 2024 Sep 16

PMID 39285151

Authors

Carlos Ichiro Kasano-Camones

Satomi Yokota

Maiko Ohashi

Noriaki Sakamoto

Daichi Ito

Yoshifumi Saito

Ryo Uchida

Kazumi Ninomiya

Yusuke Inoue

Affiliations

Soon will be listed here.

Abstract

The complement system plays an important role in biological defense as an effector to eliminate microorganisms that invade an organism and it is composed of more than 50 proteins, most of which are produced in the liver. Of these proteins, the mRNA expression of C3 and Cfb is known to be positively regulated by the nuclear receptor HNF4α. To investigate whether HNF4α regulates the complement system, we analyzed the hepatic expression of genes involved in the complement activation pathway and membrane attack complex (MAC) formation within the complement system using liver-specific Hnf4a-null mice (Hnf4a mice) and tamoxifen-induced liver-specific Hnf4a-null mice (Hnf4a mice). We found that hepatic expression of many complement genes including C8a, C8b, C8g, and C9 that are involved in formation of the MAC was markedly decreased in Hnf4a mice and Hnf4a mice. Furthermore, expression of C8A, C8B, and C8G was also decreased in human hepatoma cell lines in which the expression of HNF4α was suppressed, and expression of C8G and C9 was induced in a human immortalized hepatocyte cell line with forced expression of HNF4α. Transactivation of C8g and C9 was dependent on HNF4α expression of HNF4α binding sites, indicating that C8g and C9 are novel target genes of HNF4α. The results suggest that hepatic HNF4α plays an important role in regulation of the complement system, mainly MAC formation.

References

Aydin Y, Kurt R, Song K, Lin D, Osman H, Youngquist B . Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A- Feedback Loop in Liver Fibrosis and Cancer Progression. Cancers (Basel). 2019; 11(10). PMC: 6827087. DOI: 10.3390/cancers11101407. View

Baidya A, Khatun M, Mondal R, Ghosh S, Chakraborty B, Mallik S . Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis. J Biomed Sci. 2022; 29(1):97. PMC: 9664717. DOI: 10.1186/s12929-022-00876-1. View

Bayly-Jones C, Bubeck D, Dunstone M . The mystery behind membrane insertion: a review of the complement membrane attack complex. Philos Trans R Soc Lond B Biol Sci. 2017; 372(1726). PMC: 5483522. DOI: 10.1098/rstb.2016.0221. View

Bonzo J, Ferry C, Matsubara T, Kim J, Gonzalez F . Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice. J Biol Chem. 2012; 287(10):7345-56. PMC: 3293558. DOI: 10.1074/jbc.M111.334599. View

Cai H, Pang Y, Wang Q, Qin W, Wei C, Li Y . Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer's disease. Alzheimers Res Ther. 2022; 14(1):181. PMC: 9720984. DOI: 10.1186/s13195-022-01133-1. View

Chong P, Lee H, Loh M, Choong L, Lin Q, So J . Upregulation of plasma C9 protein in gastric cancer patients. Proteomics. 2010; 10(18):3210-21. PMC: 3760195. DOI: 10.1002/pmic.201000127. View

Ferrin G, Ranchal I, Llamoza C, Rodriguez-Peralvarez M, Romero-Ruiz A, Aguilar-Melero P . Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE. Liver Int. 2013; 34(3):438-46. DOI: 10.1111/liv.12277. View

Foley J . Examining coagulation-complement crosstalk: complement activation and thrombosis. Thromb Res. 2016; 141 Suppl 2:S50-4. DOI: 10.1016/S0049-3848(16)30365-6. View

Fu X, Ju J, Lin Z, Xiao W, Li X, Zhuang B . Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice. Sci Rep. 2016; 6:30239. PMC: 4957234. DOI: 10.1038/srep30239. View

10.

Garnier G, Circolo A, Colten H . Constitutive expression of murine complement factor B gene is regulated by the interaction of its upstream promoter with hepatocyte nuclear factor 4. J Biol Chem. 1996; 271(47):30205-11. DOI: 10.1074/jbc.271.47.30205. View

11.

Gialeli C, Gungor B, Blom A . Novel potential inhibitors of complement system and their roles in complement regulation and beyond. Mol Immunol. 2018; 102:73-83. DOI: 10.1016/j.molimm.2018.05.023. View

12.

Grumach A, Kirschfink M . Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol. 2014; 61(2):110-7. DOI: 10.1016/j.molimm.2014.06.030. View

13.

Gullstrand B, Martensson U, Sturfelt G, Bengtsson A, Truedsson L . Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol. 2009; 156(2):303-11. PMC: 2759479. DOI: 10.1111/j.1365-2249.2009.03896.x. View

14.

Hayhurst G, Lee Y, Lambert G, Ward J, Gonzalez F . Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 2001; 21(4):1393-403. PMC: 99591. DOI: 10.1128/MCB.21.4.1393-1403.2001. View

15.

Inai S, Akagaki Y, Moriyama T, Fukumori Y, Yoshimura K, Ohnoki S . Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors. Int Arch Allergy Appl Immunol. 1989; 90(3):274-9. DOI: 10.1159/000235037. View

16.

Inoue Y, Hayhurst G, Inoue J, Mori M, Gonzalez F . Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4alpha (HNF4alpha ). HNF4alpha regulates ornithine transcarbamylase in vivo. J Biol Chem. 2002; 277(28):25257-65. DOI: 10.1074/jbc.M203126200. View

17.

Inoue Y, Peters L, Yim S, Inoue J, Gonzalez F . Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression. J Mol Med (Berl). 2006; 84(4):334-44. DOI: 10.1007/s00109-005-0013-5. View

18.

Kemper C, Pangburn M, Fishelson Z . Complement nomenclature 2014. Mol Immunol. 2014; 61(2):56-8. DOI: 10.1016/j.molimm.2014.07.004. View

19.

Kim D, Song W . Membrane complement regulatory proteins. Clin Immunol. 2005; 118(2-3):127-36. DOI: 10.1016/j.clim.2005.10.014. View

20.

Kim J, Afridi R, Han J, Jung H, Kim S, Hwang E . Gamma subunit of complement component 8 is a neuroinflammation inhibitor. Brain. 2020; 144(2):528-552. DOI: 10.1093/brain/awaa425. View